Chemours (CC) vs Ingevity (NGVT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Ingevity (NGVT) has outperformed Chemours (CC) over the past year, gaining 32.7% versus a loss of 7.4%. Over five years, NGVT leads with a -9.0% price change compared with -54.7% for CC. Ingevity is the larger company by market cap ($2.44 billion vs $2.10 billion), about 1.2 times the size.
On valuation, Chemours trades at a lower forward P/E (7.2x vs 11.8x for Ingevity). Chemours pays a dividend yielding 2.50%, while Ingevity does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CC | NGVT |
|---|---|---|
| Share price | $13.98 | $70.92 |
| Market cap | $2.10B | $2.44B |
| 1-day change | -0.71% | -2.58% |
| YTD return | +18.58% | +19.84% |
| 1-year return | -7.36% | +32.66% |
| 5-year return | -54.74% | -9.02% |
| P/E ratio (TTM) | — | 101.31 |
| Forward P/E | 7.25 | 11.79 |
| EPS (TTM) | $-2.02 | $0.70 |
| Dividend yield | 2.50% | 0.00% |
| Annual dividend | $0.35 | $0.00 |
| Revenue (latest FY) | — | $1.17B |
| Revenue growth (YoY) | — | -2.71% |
| Net income (latest FY) | — | $-167.10M |
| Gross margin | — | 39.53% |
| Operating margin | — | 35.86% |
| Net margin | — | -14.31% |
| 52-week high | $28.67 | $79.29 |
| 52-week low | $10.44 | $45.85 |
| Distance from 52-week high | -51.24% | -10.56% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +31.12% | +25.49% |
| Average volume | 2.27M | 247.72K |
| Shares outstanding | 150.50M | 34.38M |
| Employees | 5,700 | 1,400 |
| Sector | Industrials | Industrials |
| Industry | Major Chemicals | Major Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NGVT has outperformed CC by 40.0 percentage points over the past year.
- Chemours offers a meaningfully higher dividend yield (2.50% vs 0.00%).
About Chemours
CC stock →The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.
Industrials · Major Chemicals · 5,700 employees
About Ingevity
NGVT stock →Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Industrials · Major Chemicals · 1,400 employees
CC vs NGVT FAQ
Which is bigger, Chemours or Ingevity?
Ingevity (NGVT) is larger, with a market capitalization of $2.44B compared with $2.10B for Chemours (CC).
Which stock has performed better over the past year, CC or NGVT?
NGVT returned +32.66% over the past 12 months, compared with -7.36% for CC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Chemours or Ingevity?
Chemours pays a dividend yielding 2.50%, while Ingevity does not currently pay a regular dividend.
Are Chemours and Ingevity in the same industry?
Yes. Both are classified in the Major Chemicals industry within the Industrials sector.